Correlation of TACC3, FGFR3, MMSET and p21 expression with the t(4;14)(p16.3;q32) in multiple myeloma.
about
Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patientsAberrations of TACC1 and TACC3 are associated with ovarian cancerIdentification of ID-1 as a potential target gene of MMSET in multiple myelomaThe transforming acidic coiled coil (TACC1) protein modulates the transcriptional activity of the nuclear receptors TR and RAR.High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2.Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes.TACC3 is essential for EGF-mediated EMT in cervical cancerHigh expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy.Role of microRNAs from monoclonal gammopathy of undetermined significance to multiple myelomaClinical implications of chromosomal abnormalities in multiple myeloma.Ten years and counting: so what do we know about t(4;14)(p16;q32) multiple myeloma.TACC3 overexpression in cholangiocarcinoma correlates with poor prognosis and is a potential anti-cancer molecular drug target for HDAC inhibitorsDownregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype.MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells.Interaction of TACC proteins with the FHL family: implications for ERK signaling.Repeats in transforming acidic coiled-coil (TACC) genes.TACC3 deregulates the DNA damage response and confers sensitivity to radiation and PARP inhibition.Oncogenic driver FGFR3-TACC3 is dependent on membrane trafficking and ERK signaling
P2860
Q24670250-24251253-8A60-4FF6-B492-A391728F3941Q24811001-F85A7343-D97D-484C-A916-7A5E25B38BE7Q28268453-6191EB58-D790-41F8-ADE6-73397852563AQ33524554-C0599634-EE43-4D90-A39E-F989CDC88C53Q33842759-DBBCC979-E7F4-4F0D-AC45-953C69D6C333Q34152192-F687AE08-786B-4E65-A595-9FD33EBCA604Q34925509-F800EB8B-845F-48ED-AECA-AFF7165589A5Q35740091-E59BEE25-2F5C-46F1-A8E3-5611FD6E6A76Q35848356-5CD3E476-81ED-47D4-9D7D-799586C43766Q35910526-C6BF3C73-A802-4BEF-B96E-3382C3D86B09Q36497416-E8CB9057-B9DA-463C-A34C-ACABBBDFD25CQ36654607-31403040-7C62-41B6-9E1C-7A34AB5BCA64Q37688959-26AB2470-DFE5-4FCB-A96F-8CF6E2612BD4Q39515650-F6B97F5B-AF8E-4217-9B93-8C2F381DAD2CQ39908262-517055E6-EE6C-4399-96EA-3074666FAB9DQ41959511-CD953FFA-0206-456A-8323-F85A9AF00B5AQ44283332-EF0EFA88-61C3-4FBB-AD5D-DD5A9E0FAD80Q48314165-B44E6080-0F65-4C21-ADC1-4165C67CED0AQ57821064-2424A359-9711-4BB4-B8E6-963DE97570A5
P2860
Correlation of TACC3, FGFR3, MMSET and p21 expression with the t(4;14)(p16.3;q32) in multiple myeloma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Correlation of TACC3, FGFR3, M ...... 16.3;q32) in multiple myeloma.
@en
Correlation of TACC3, FGFR3, M ...... 16.3;q32) in multiple myeloma.
@nl
type
label
Correlation of TACC3, FGFR3, M ...... 16.3;q32) in multiple myeloma.
@en
Correlation of TACC3, FGFR3, M ...... 16.3;q32) in multiple myeloma.
@nl
prefLabel
Correlation of TACC3, FGFR3, M ...... 16.3;q32) in multiple myeloma.
@en
Correlation of TACC3, FGFR3, M ...... 16.3;q32) in multiple myeloma.
@nl
P2093
P2860
P1476
Correlation of TACC3, FGFR3, M ...... 16.3;q32) in multiple myeloma.
@en
P2093
James Peter Stewart
John Shaughnessy
Madhumita Santra
Terence R J Lappin
P2860
P356
10.1111/J.1365-2141.2004.04996.X
P407
P577
2004-07-01T00:00:00Z